Pricing Log in Create free account

Onconetix, Inc. (ONCO) vs Panbela Therapeutics Inc. (PBLA)

Onconetix, Inc. and Panbela Therapeutics Inc. are both Biotechnology companies. Onconetix, Inc. and Panbela Therapeutics Inc. are of similar size ($3.4M and $3.2M). Panbela Therapeutics Inc. has the higher net margin (0.00% vs −1,578.6%) and the higher return on invested capital (0.00% vs −135.4%). Across the 12 metrics below, Panbela Therapeutics Inc. leads on 8 and Onconetix, Inc. on 4.

Valuation

Metric ONCO PBLA Biotechnology median
P/E n/m n/m 10.60
P/S 23.65 n/m 9.40
P/B 1.13 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 14.63 n/m 9.02
Earnings yield (2,931.13%) (322,700.00%) (32.88%)
Free cash flow yield (67.68%) (29,656.02%) (23.13%)

Profitability

Metric ONCO PBLA Biotechnology median
Gross margin 80.38% — 68.51%
Operating margin (2,524.73%) 0.00% 0.00%
Net margin (1,578.60%) 0.00% 0.00%
Free cash flow margin (1,595.90%) 0.00% 0.00%
Return on equity (105.23%) 270.37% (51.96%)
Return on assets (57.37%) (353.47%) (46.06%)
Return on invested capital (135.42%) 0.00% 0.00%

Growth

Metric ONCO PBLA Biotechnology median
Revenue growth (TTM) (51.33%) — 6.76%
EPS growth (last fiscal year) 99.09% 99.43% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ONCO PBLA Biotechnology median
Debt to equity 0.00 (0.23) 0.00
Current ratio 2.21 0.26 4.97
Net debt to EBITDA 0.29 (0.10) 1.01

Dividend

Metric ONCO PBLA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ONCO PBLA Biotechnology median
Market cap 3.24m 3.35m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack